An Iodine Balance Study to Investigate the Recommended Iodine Intake in an Elderly Population - Trial NCT06218043
Access comprehensive clinical trial information for NCT06218043 through Pure Global AI's free database. This phase not specified trial is sponsored by Wenxing Guo and is currently Recruiting. The study focuses on Nutrition, Healthy. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Wenxing Guo
Tianjin Medical University
Timeline & Enrollment
N/A
Apr 01, 2023
Dec 31, 2025
Primary Outcome
Iodine intake,Iodine excretion
Summary
Current Chinese dietary iodine reference intake (DRIs) standards lack direct data on
 recommended iodine intake (RNI) in the elderly. The elderly have a high prevalence of thyroid
 diseases. The risk threshold of iodine intake in the elderly is unknown. Identifying the
 appropriate iodine intake for the elderly to maintain optimal thyroid function to reduce the
 burden on medical resources is a public health issue requiring high attention. The iodine
 balance study is an important method for exploring physiological iodine requirements. Few
 iodine balance studies have been conducted in the elderly. This study aimed to conduct an
 iodine balance study and provide information on the appropriate iodine intake level for
 elderly people.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06218043
Non-Device Trial